#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine leiomyosarcoma Breast angiosarcoma Mitochondrial myopathy Craniocerebral injury Superficial vein thrombosis Arginase deficiency Basal cell naevus syndrome Malignant fibrous histiocytoma Arteriovenous malformation Spinal muscular atrophy Myelodysplastic syndrome with excess blasts Pyruvate kinase deficiency anaemia Rectal cancer Acute graft versus host disease Vulval cancer More trials…

    Learn about Rare Diseases

    Pulmonary sarcoidosis – Basic Information Synovial sarcoma recurrent – Treatment Factor IX deficiency – Basic Information Indolent systemic mastocytosis Osteosarcoma recurrent – Trials in Disease Splenic marginal zone lymphoma – Treatment Inclusion body myositis – Diagnostics Marginal zone lymphoma refractory – Life with Disease Osteosarcoma metastatic Antithrombin III deficiency – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    NALDEMEDINE Istem-01 Clic-1901 Cart Tioguanine Mexiletine Avibactam Sodium Apl-101 Pseudoephedrine Hydrochloride ROC-101 HYDROCHLORIDE Prednisolone Sodium Succinate Cisplatin Ieramilimab Glycine Laronidase GRISNILIMAB SETARITOX Niflumic Acid POTASSIUM HYDROXIDE VANDETANIB Tisagenlecleucel TRV045 More therapies…

    Learn about Your Condition

    Colon cancer metastatic Pemphigoid Skin disorder Hypertonic bladder Post procedural swelling Liver transplant rejection Porphyria non-acute Rhabdoid tumour Dyskinesia Pelizaeus-Merzbacher disease Malignant mast cell neoplasm Renal impairment Intracranial aneurysm Glomerulonephritis acute Neoplasm malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • [18F]CPFPX PET in Patients With Drug-Resistant Epilepsy and Healthy Subjects

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • [18F]CPFPX
    France

  • A study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer’s disease

    Not yet recruiting

    4 1
    Investigated Diseases:
    • Agitation
    • Dementia Alzheimer’s type
    Czechia Germany Italy Poland Slovakia Spain

  • Study to evaluate the effect of methylphenidate hydrochloride on the time to wake up in patients in a coma due to acute brain injury

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Coma
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    Austria Denmark France Germany

  • A study to evaluate the effectiveness of semaglutide for treating obesity caused by craniopharyngioma in children aged 12 to 17 years.

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Semaglutide
    France

  • A study of RVU120 and everolimus for children with recurrent or progressive medulloblastoma

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    • Everolimus
    Poland

  • Effect of cladribine tablets on immune synapse in patients with relapsing multiple sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cladribine
    Greece
Previous Page
1 … 62 63 64 65 66 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!